- Home
- TNGX vs AAP Comparison
TNGX vs AAP Comparison
Compare TNGX & AAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNGX | AAP |
|---|---|---|
| Founded | 2014 | 1929 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto & Home Supply Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.6B |
| IPO Year | 2020 | 2002 |
Fundamental Metrics
Financial Performance| Metric | TNGX | AAP |
|---|---|---|
| Price | $23.35 | $57.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 17 |
| Target Price | $21.78 | ★ $53.50 |
| AVG Volume (30 Days) | ★ 2.8M | 1.2M |
| Earning Date | 05-08-2026 | 05-21-2026 |
| Dividend Yield | N/A | ★ 1.79% |
| EPS Growth | 26.89 | ★ 113.01 |
| EPS | N/A | ★ 0.73 |
| Revenue | $62,384,000.00 | ★ $8,601,000,000.00 |
| Revenue This Year | N/A | $0.35 |
| Revenue Next Year | N/A | $2.51 |
| P/E Ratio | ★ N/A | $79.56 |
| Revenue Growth | ★ 48.29 | N/A |
| 52 Week Low | $1.12 | $30.84 |
| 52 Week High | $28.41 | $70.00 |
Technical Indicators
Market Signals| Indicator | TNGX | AAP |
|---|---|---|
| Relative Strength Index (RSI) | 52.39 | 53.76 |
| Support Level | $7.08 | $56.96 |
| Resistance Level | $28.41 | $61.94 |
| Average True Range (ATR) | 1.80 | 2.24 |
| MACD | -0.47 | -0.22 |
| Stochastic Oscillator | 34.51 | 37.90 |
Price Performance
Historical ComparisonAbout TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About AAP Advance Auto Parts Inc.
Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About half of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models. The retailer primarily competes on inventory availability and service speed, making the operating efficiency of its hub-and-spoke distribution model critical to meeting customer needs.